Evidence map›Paper›PMID 30642386›Full record

ArticleTrials2019

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

David S Lawrence, Nabila Youssouf, Síle F Molloy, Alexandre Alanio, Melanie Alufandika, David R Boulware, Timothée Boyer-Chammard, Tao Chen, Francoise Dromer, Admire Hlupeni and 19 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Trials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.Current neurology and neuroscience reports · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

David S LawrenceDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. david.s.lawrence@lshtm.ac.uk.
Nabila YoussoufDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Síle F MolloyResearch Centre for Infection and Immunity, St George's University of London, London, UK.
Alexandre AlanioMolecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
Melanie AlufandikaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
David R BoulwareInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Timothée Boyer-ChammardMolecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
Tao ChenDepartment of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Francoise DromerMolecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
Admire HlupeniDepartment of Medicine, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Harare, Zimbabwe.
William HopeDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Mina C HosseinipourLilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
Cecilia KanyamaLilongwe Medical Relief Trust (UNC Project), Lilongwe, Malawi.
Oliver LortholaryMolecular Mycology Unit and National Reference Centre for Invasive Mycoses, Institut Pasteur, Paris, France.
Angela LoyseResearch Centre for Infection and Immunity, St George's University of London, London, UK.
David B MeyaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Mosepele MosepeleBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Conrad MuzooraInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Henry C MwandumbaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Chiratidzo E NdhlovuDepartment of Medicine, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Harare, Zimbabwe.
Louis NiessenDepartment of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Charlotte SchutzWellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.
Katharine E StottMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Duolao WangDepartment of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
David G LallooDepartment of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Graeme MeintjesWellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.
Shabbar JaffarDepartment of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Thomas S HarrisonResearch Centre for Infection and Immunity, St George's University of London, London, UK.
Joseph N JarvisDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Funding

Malawi HIV Implementation Research Scientist Training Program (MHIRST)D43TW010060 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MINA CHRISTINE HOSSEINIPOUR, Victor Mwapasa · 2015 to 2026
$3.8M
FIC NIH HHS D43 TW010060Medical Research Council MC_PC_MR/P006922/1
6 · The paper itself

Abstract

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.

Identifiers

PMID30642386
PMCPMC6332521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.